Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-015005
Filing Date
2025-06-13
Accepted
2025-06-13 11:04:18
Documents
1
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3075
  Complete submission text file 0001641172-25-015005.txt   4719
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Issuer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2117 SOUTHWEST HIGHWAY 484 OCALA FL 34473
Business Address
Equels Thomas K (Reporting) CIK: 0001450324 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-27072 | Film No.: 251045140